496 related articles for article (PubMed ID: 30027284)
1. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
[TBL] [Abstract][Full Text] [Related]
2. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers.
Wang M; Sharma A; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF; Huh WK; Adjei Boakye E
Cancer Epidemiol; 2020 Feb; 64():101649. PubMed ID: 31816512
[TBL] [Abstract][Full Text] [Related]
4. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
[TBL] [Abstract][Full Text] [Related]
6. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
7. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
8. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
9. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
12. Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years.
Nikkilä R; Hirvonen E; Haapaniemi A; Tapiovaara L; Pitkäniemi J; Malila N; Mäkitie A
Acta Oncol; 2023 Oct; 62(10):1322-1330. PubMed ID: 37672344
[TBL] [Abstract][Full Text] [Related]
13. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
14. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer.
Morris LG; Sikora AG; Hayes RB; Patel SG; Ganly I
Cancer Causes Control; 2011 May; 22(5):671-9. PubMed ID: 21327458
[TBL] [Abstract][Full Text] [Related]
15. Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study.
Chan JY; Gooi Z; Mydlarz WK; Agrawal N
Ear Nose Throat J; 2016 Dec; 95(12):E7-E11. PubMed ID: 27929600
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.
Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G;
Oral Oncol; 2014 Dec; 50(12):1169-76. PubMed ID: 25301563
[TBL] [Abstract][Full Text] [Related]
17. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L
J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
19. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
[TBL] [Abstract][Full Text] [Related]
20. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
